I
Illumina, Inc.
$273.51
Mkt Cap 41.30B
Maker of DNA sequencing and microarray systems used for genomic research, clinical diagnostics and consumer genomics.
illumina.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
Run a full DCF model with Monte Carlo simulation.
Key Metrics
Loading full analysis…
REVENUE TTM
$4.49B
FCF TTM
$931.0M
P/E RATIO
50.1x
P/FCF
44.4x
Running full 6-factor analysis…